癌におけるACTL6Aの腫瘍性作用と予後値:体系的なレビューとメタ解析
Soumya Patil1, Raushan Kumar Chaudhary2, Prakash Patil3
1Department of Pharmacy Practice, NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Nitte (Deemed to be University), India.
まとめ
アクチンのようなタンパク質6A (ACTL6A) は癌の進行と悪い結果をもたらす. ACTL6Aの過剰発現は生存率の低下,より大きな腫瘍,およびより高いグレードに関連しており,予後マーカーとしての可能性を示している.
科学分野:
- 腫瘍学
- 分子生物学
- 遺伝学
背景:
- アクチン類似タンパク質6A (ACTL6A) は,がんに関与するSWI/SNF複合体のサブユニットである.
- 腫瘍発生と臨床結果におけるその役割の徹底的な評価が必要である.
研究 の 目的:
- 癌の病理生理学におけるACTL6Aの役割を体系的に検討し,メタ分析する.
- 人間の癌におけるACTL6Aの予後的意義を評価する.
主な方法:
- 2024年12月31日までのPubMed,Scopus,Web of Scienceの体系的な文献検索
- 癌におけるACTL6Aに関する研究と,ACTL6A発現に対する危険性比を報告した研究を含む.
- 6つの研究 (n=863) のメタ分析
主要な成果:
- 主要なシグナル伝達経路 (HIPPO- YAP,PI3K/ AKT,NOTCH,Wnt/ β- catenin) 経由による腫瘍発生,侵入,転移におけるACTL6Aの役割を強調した39の研究が検討された.
- ACTL6Aの過剰発現は,全生存率の低下と有意に相関していた (p=0. 001).
- 過剰発現はまた,より大きな腫瘍サイズ (p<0. 01) とより高い腫瘍グレード (p=0. 002) と関連付けられました.
結論:
- ACTL6Aは,がんの進行と有害な臨床結果を促進する重要な腫瘍発生因子として作用します.
- ACTL6Aは腫瘍学における予後マーカーとしての可能性を示しています.
- ACTL6Aに対する標的治療戦略は有益である.
関連する概念動画
lncRNA - Long Non-coding RNAs
8.9K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.9K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Cancer-Critical Genes I: Proto-oncogenes
9.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
The Retinoblastoma Gene
4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K


